9pcq: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "9pcq" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
==Phosphorylation of a Conserved Aspartate at the Eukaryotic Elongation Factor 2 Kinase Catalytic Site== | |||
<StructureSection load='9pcq' size='340' side='right'caption='[[9pcq]], [[Resolution|resolution]] 2.30Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[9pcq]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9PCQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9PCQ FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ADP:ADENOSINE-5-DIPHOSPHATE'>ADP</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=PHD:ASPARTYL+PHOSPHATE'>PHD</scene>, <scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9pcq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9pcq OCA], [https://pdbe.org/9pcq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9pcq RCSB], [https://www.ebi.ac.uk/pdbsum/9pcq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9pcq ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/EF2K_HUMAN EF2K_HUMAN] Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced.<ref>PMID:14709557</ref> <ref>PMID:9144159</ref> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Eukaryotic elongation factor 2 kinase (eEF-2K) is a member of the alpha-kinase family of atypical serine/threonine kinases. eEF-2K, the only calmodulin-activated alpha-kinase, phosphorylates the ribosome-associated GTPase, eukaryotic elongation factor 2 (eEF-2), suppressing translational elongation. alpha-kinases, including eEF-2K, possess catalytic site geometries that are distinct from those of typical kinases, suggesting possible divergence in their phospho-transfer mechanisms. Unlike typical protein kinases, where chemistry is known to proceed through a sequential mechanism involving a ternary kinase-substrate-ATP*Mg(2+) complex, the nature of the chemical step catalyzed by alpha-kinases remains poorly defined. Here, multiple orthogonal lines of evidence, including a crystal structure and solution-state mass spectrometry data, suggest phosphorylation of a catalytically essential aspartate residue (D284) at the eEF-2K active site. Previous crystallographic evidence of the presence of a phospho-aspartate at an equivalent position (D766) in the related Dictyostelium alpha-kinase MHCK-A strongly suggests that this species represents a conserved active-site feature in alpha-kinase family members, despite their disparate modes of activation. This observation, together with existing kinetics data on eEF-2K, raises the possibility that phospho-transfer chemistry in alpha-kinases occurs via an ordered stepwise mechanism involving a phospho-enzyme intermediate, contrasting with typical protein kinases. | |||
Phosphorylation of a conserved aspartate in the catalytic site of eukaryotic elongation factor 2 kinase.,Piserchio A, Isiorho EA, Abzalimov R, Dalby KN, Ghose R Protein Sci. 2026 Jan;35(1):e70442. doi: 10.1002/pro.70442. PMID:41432361<ref>PMID:41432361</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: Dalby | <div class="pdbe-citations 9pcq" style="background-color:#fffaf0;"></div> | ||
[[Category: | == References == | ||
[[Category: Isiorho | <references/> | ||
[[Category: | __TOC__ | ||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Large Structures]] | |||
[[Category: Dalby K]] | |||
[[Category: Ghose R]] | |||
[[Category: Isiorho EA]] | |||
[[Category: Piserchio A]] | |||